Clin2
NCT07437157Likely a fitRecruiting

Hong Kong diabetes fatty liver disease study

Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 Diabetes (T2DM)

Part of Hormones & metabolism clinical trials.

This research study looks at people with type 2 diabetes to learn more about fatty liver disease. By joining, you may help doctors better understand how these conditions are linked and improve future care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have type 2 diabetes
  • You are 18 years old or older
  • You are able and willing to give written permission to take part

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07706010Not yet recruiting
Heart health in type 2 diabetes with fatty liver disease

This study follows people who have both type 2 diabetes and fatty liver disease to see how these conditions affect heart health over time. By participating, you'll help researchers learn more about lowering your risk of heart problems.

Hanzhou, Zhejiang
NCT07083336Recruiting
Diet study for type 2 diabetes with fatty liver disease

This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.

Yichang, Hubei
NCT06984510Recruiting
Early aging and diabetes risk with fatty liver

This study looks at how early biological aging might increase the chance of developing type 2 diabetes in people with a fatty liver (a condition called MASLD). It uses routine health check-up data to understand the link.

Ningbo, Zhejiang
NCT07246421Recruiting
Glucagon resistance in fatty liver and diabetes

This study looks at how people with fatty liver and type 2 diabetes respond to glucagon, a hormone that helps control blood sugar. It may help researchers understand a condition called 'glucagon resistance' and find better treatments.

Aarhus
NCT07133854Not yet recruiting
Fat tissue function and liver fat in type 1 diabetes

This study looks at how fat tissue works differently in people with type 1 diabetes who have extra belly fat, and how that may lead to fat building up in the liver. It compares them to people without diabetes to better understand the link.

Sherbrooke, Quebec
NCT07247409Recruiting
Hong Kong Diabesity Registry Study

This study is building a registry of people in Hong Kong who have both type 2 diabetes and obesity. By joining, you help researchers understand how these conditions interact and find better ways to treat them.

Hong Kong

Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.